Lincoln Pharmaceuticals consolidated net profit declines 25.93% in the December 2024 quarter
Sales rise 0.07% to Rs 146.55 crore
Net profit of Lincoln Pharmaceuticals declined 25.93% to Rs 20.77 crore in the quarter ended December 2024 as against Rs 28.04 crore during the previous quarter ended December 2023. Sales rose 0.07% to Rs 146.55 crore in the quarter ended December 2024 as against Rs 146.45 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales146.55146.45 0 OPM %16.1420.25 -PBDT31.9140.52 -21 PBT28.6837.71 -24 NP20.7728.04 -26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 13 2025 | 4:46 PM IST